Until recently, the division of pulmonary carcinomas into small cell lung cancer (SCLC) and
non-small cell lung cancer (NSCLC) was adequate for therapy selection. Due to the …

Objective To establish evidence-based recommendations for the molecular analysis of lung
cancers that are that are required to guide EGFR-and ALK-directed therapies, addressing …

The pathological diagnosis of lung cancer has largely been based on the morphological
features observed microscopically. Recent innovations in molecular and genetic technology …

Purpose: The objectives of this study were to determine the incidence of the MYB-NFIB
fusion in salivary adenoid cystic carcinoma (ACC), to establish the clinicopathologic …

Pulmonary mucoepidermoid carcinoma is an uncommon but distinctive manifestation of
mucoepidermoid carcinoma. Pulmonary mucoepidermoid carcinoma occurs in adults and …

Introduction Pulmonary mucoepidermoid carcinoma (PMEC) is an uncommon neoplasm of
the lung and the main salivary gland-type lung carcinoma. The aims of this study were to …

Pulmonary mucoepidermoid carcinoma (PMEC) is the most common malignant salivary
gland tumor in the lungs and accounts for 0.1‐0.2% of all lung malignancies in adults. It has …

Adenoid cystic carcinoma of the lung (ACCL) is a rare salivary gland‑type malignant
neoplasm that occurs infrequently as a primary tumor of the airway. Owing to its low …

The CRTC1‐MAML2 fusion oncogene underlies the etiology of mucoepidermoid salivary
gland carcinoma (MEC) where it confers a favorable survival outcome as compared with …

Background: Epidermal growth factor receptor (EGFR) is highly expressed in adenoid cystic
carcinoma (ACC). The efficacy and toxicity of cetuximab with concomitant platinum-based …